• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

NBS:US

5.2300 USD 0.1700 3.15%

As of 20:10:00 ET on 10/22/2014.

Snapshot for NeoStem Inc (NBS)

Open: 5.5000 Day's Range: 5.1201 - 5.5000 Volume: 199,478
Previous Close: 5.4000 52wk Range: 4.5600 - 8.2900 1-Yr Rtn: -24.53%

Stock Chart for NBS

No chart data available.
  • NBS:US 5.2500
  • 1D
  • 1M
  • 1Y
5.4000
Interactive NBS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NBS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.8100
Est. EPS (USD) (12/2014) -1.5970
Est. PEG Ratio -
Market Cap (M USD) 184.84
Shares Outstanding (M) 35.34
30 Day Average Volume 178,124
Price/Book (mrq) 2.3415
Price/Sale (ttm) 8.4006
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NBS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NBS

NeoStem, Inc. develops and manufactures cell therapies. The Company through its subsidiaries offers contract manufacturing services and is developing a cell therapy for the treatment of cardiovascular disease.

Robin L SmithChief Executive OfficerRobert Dickey IVChief Financial Officer
Andrew L PecoraChief Visionary OfficerDouglas W LosordoChief Medical Officer
More Company Profile & Key Executives for NBS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil